KAS
AZN icon

Kestra Advisory Services’s AstraZeneca AZN Stock Holding History

Kestra Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67M Buy
45,717
+1,889
+4% +$355K 0.03% 566
2026
Q1 		$8.64M Sell
43,828
-6,476
-13% -$1.25M 0.03% 519
2025
Q4 		$9.25M Buy
50,304
+1,956
+4% +$343K 0.04% 445
2025
Q3 		$7.42M Buy
48,348
+11,501
+31% +$1.74M 0.03% 506
2025
Q2 		$5.15M Buy
36,847
+2,427
+7% +$340K 0.03% 626
2025
Q1 		$5.06M Sell
34,420
-6,610
-16% -$956K 0.02% 575
2024
Q4 		$5.38M Buy
41,030
+337
+0.8% +$47.2K 0.03% 547
2024
Q3 		$6.34M Sell
40,693
-7,080
-15% -$1.14M 0.03% 514
2024
Q2 		$7.45M Buy
47,773
+2,779
+6% +$418K 0.04% 455
2024
Q1 		$6.1M Buy
44,994
+5,928
+15% +$785K 0.04% 460
2023
Q4 		$5.26M Buy
39,066
+1,091
+3% +$142K 0.04% 431
2023
Q3 		$5.14M Buy
37,975
+6,165
+19% +$842K 0.05% 374
2023
Q2 		$4.55M Sell
31,810
-3,501
-10% -$515K 0.05% 399
2023
Q1 		$4.9M Sell
35,311
-22,663
-39% -$3.05M 0.05% 359
2022
Q4 		$7.86M Buy
57,974
+5,557
+11% +$697K 0.07% 302
2022
Q3 		$5.75M Sell
52,417
-1,368
-3% -$174K 0.06% 339
2022
Q2 		$7.11M Buy
53,785
+8,535
+19% +$1.12M 0.07% 281
2022
Q1 		$6M Buy
45,250
+4,291
+10% +$515K 0.06% 322
2021
Q4 		$4.77M Sell
40,959
-2,682
-6% -$316K 0.05% 384
2021
Q3 		$5.24M Buy
43,641
+11,733
+37% +$1.37M 0.05% 371
2021
Q2 		$3.82M Sell
31,908
-862
-3% -$94.6K 0.04% 431
2021
Q1 		$3.26M Buy
32,770
+2,935
+10% +$295K 0.04% 444
2020
Q4 		$2.99M Buy
29,835
+9,108
+44% +$965K 0.03% 465
2020
Q3 		$2.27M Buy
+20,727
New +$2.31M 0.04% 399

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kestra Advisory Services's AZN Position: Q2 2026 in Review

Kestra Advisory Services increased its AstraZeneca (AZN) stake by 4.3% in Q2 2026, buying an estimated $355K and bringing the position to 45,717 shares worth $8.67M. The position accounts for 0.03% of the portfolio, ranked #566.

Kestra Advisory Services first reported a position in AZN in Q3 2020 and has held it in 24 quarters since. The position peaked at $9.25M in Q4 2025. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Kestra Advisory Services held 45,717 shares of AstraZeneca worth $8.67M as of Q2 2026.
  • Kestra Advisory Services bought 1,889 AstraZeneca shares in Q2 2026, an estimated $355K.
  • AstraZeneca made up 0.03% of Kestra Advisory Services's portfolio in Q2 2026, its #566 holding.
  • Kestra Advisory Services first reported a position in AstraZeneca in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's AstraZeneca position peaked at $9.25M in Q4 2025.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.